Lois Anzelowitz Levine, MA, is the associate editorial director of 

Articles

Investigators studied 2 infants experiencing seizures, small head size, and developmental delays born of mothers who had contracted COVID-19 during pregnancy.

New study shows COVID-19 infections in 2 pregnant women caused brain damage in newborns

Tori Whitacre Martonicz is the senior editor of 

.  She has been a writer and editor for over 30 years and has an MA and BA in English Composition/Literature from the University of Akron in Akron, OH. She lives in Ohio with her husband; son; 2 tiny dogs, Selena Brigid Sophia and Doctor Danger Dog; and a big black cat, Freya. She loves reading, writing, gardening, and spending time with her loved ones. Contact her through her email: tmartonicz@mjhlifesciences.com.

Legionnaires’ disease is a severe infection and fatal in 10% of cases. 


Two Cases of Legionnaires’ Disease Linked to Public Gym in Illinois 

KEVIN KAVANAGH, MD, is the founder of the patient advocacy group Health Watch USA

Editorial Advisory Board, and a frequent contributor to 

Establishing a permanent system for monitoring the persistence and emergence of dangerous pathogens is necessary, especially COVID-19.

Opinion: COVID-19 Expanded Reporting Systems Should Continue

The vaccine is approved for use in adults aged 60 and older to prevent lower respiratory tract disease caused by RSV. 

Breaking: FDA Approves First-Ever RSV Vaccine

Saskia v. Popescu, PhD, MPH, MA, CIC is an infection preventionist and infectious disease epidemiologist. Currently, she serves as a senior fellow at the Council on Strategic Risks, where she works to address global health security issues, including national policies impacting health care readiness and biodefense. Saskia is also an assistant professor at George Mason University, teaching courses on health care preparedness and epidemiology in policy. She holds a PhD in biodefense from George Mason University, where her research focused on the political and economic obstacles to investing in infection prevention, a MPH in infectious disease epidemiology, a MA in international security studies--both from the University of Arizona. Prior to her work at CSR, Saskia helped lead global health response at Netflix and was a senior infection preventionist with HonorHealth in Arizona. She has worked with the WHO, supported multiple NASEM workshops and reports, and supports NGO engagement within the Biological Weapons Convention at the UN. Saskia’s work is on building health care biopreparedness and readiness for infectious disease threats, especially in larger global health security efforts.

Saskia v. Popescu, PhD, MPH, MA, CIC, gives the latest on COVID-19, Marburg Virus Disease, and a 1-hit STI antibiotic plan.

Hot Topics in IPC: STI Antibiotic Plans, Marburg, COVID-19, and Medicine's Rat Problem

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending April 23, 2023.


Weekly Rounds: Marburg in the Lab, IPs' Role in Dentistry, and IP Risk in Water Management

Sulbactam-durlobactam is under priority review (PDUFA; May 29, 2023). 

AMDAC Votes Unanimously in Favor of Possible Bacterial Pneumonia Therapy 

Videos

Despite the recent CDC warning and frightening media coverage, understanding which patients are at a higher risk of Candida auris is important too. The lead author of the recent CDC's study spoke to ICT's sister brand for further insights on the threat. 

Candida auris: Using Public Health Messaging to Address Prevention

Saskia v. Popescu, PhD, MPH, MA, CIC, gives the latest on Candida auris, Marburg Virus Disease, and eye drops from EzriCare and Delsam Pharma. 

Hot Topics in IPC: Candida auris, Marburg Virus, and Pseudomonas From Eye Drops

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending March 5, 2023.


All News